TY - JOUR
T1 - Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice
AU - Vroegrijk, Irene O. C. M.
AU - van Diepen, Janna A.
AU - van den Berg, Sjoerd
AU - Westbroek, Irene
AU - Keizer, Hiskias
AU - Gambelli, Luisa
AU - Hontecillas, Raquel
AU - Bassaganya-Riera, Josep
AU - Zondag, Gerben C. M.
AU - Romijn, Johannes A.
AU - Havekes, Louis M.
AU - Voshol, Peter J.
PY - 2011
Y1 - 2011
N2 - Pomegranate seed oil has been shown to protect against diet induced obesity and insulin resistance. To characterize the metabolic effects of punicic acid on high fat diet induced obesity and insulin resistance. High-fat diet or high-fat diet with 1% Pomegranate seed oil (PUA) was fed for 12weeks to induce obesity and insulin resistance. We assessed body weight and composition (pSABRE DEXA-scan), energy expenditure (Columbus Instruments) and insulin sensitivity at the end of the 12weeks. PSO intake resulted in a lower body weight, 30.5±2.9 vs 33.8±3.2g PSO vs HFD respectively, p=0.02, without affecting food intake or energy expenditure. The lower body weight was fully explained by a decreased body fat mass, 3.3±2.3 vs 6.7±2.7g for PSO and HFD fed mice, respectively, p=0.02. Insulin clamps showed that PSO did not affect liver insulin sensitivity but clearly improved peripheral insulin sensitivity, 164±52% vs 92±24% for PSO and HFD fed mice respectively, p=0.01. We conclude that dietary PSO ameliorates high-fat diet induced obesity and insulin resistance in mice, independent of changes in food intake or energy expenditure
AB - Pomegranate seed oil has been shown to protect against diet induced obesity and insulin resistance. To characterize the metabolic effects of punicic acid on high fat diet induced obesity and insulin resistance. High-fat diet or high-fat diet with 1% Pomegranate seed oil (PUA) was fed for 12weeks to induce obesity and insulin resistance. We assessed body weight and composition (pSABRE DEXA-scan), energy expenditure (Columbus Instruments) and insulin sensitivity at the end of the 12weeks. PSO intake resulted in a lower body weight, 30.5±2.9 vs 33.8±3.2g PSO vs HFD respectively, p=0.02, without affecting food intake or energy expenditure. The lower body weight was fully explained by a decreased body fat mass, 3.3±2.3 vs 6.7±2.7g for PSO and HFD fed mice, respectively, p=0.02. Insulin clamps showed that PSO did not affect liver insulin sensitivity but clearly improved peripheral insulin sensitivity, 164±52% vs 92±24% for PSO and HFD fed mice respectively, p=0.01. We conclude that dietary PSO ameliorates high-fat diet induced obesity and insulin resistance in mice, independent of changes in food intake or energy expenditure
U2 - https://doi.org/10.1016/j.fct.2011.03.037
DO - https://doi.org/10.1016/j.fct.2011.03.037
M3 - Article
C2 - 21440024
SN - 0278-6915
VL - 49
SP - 1426
EP - 1430
JO - Food and chemical toxicology
JF - Food and chemical toxicology
IS - 6
ER -